UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 74

Sortiert nach

Integrating novel immunotherapeutic approaches in organ-preserving therapies for bladder cancer

British journal of pharmacology, 2024-01

2024

Volltextzugriff (PDF)

Prognostic factors for progression in atypical meningioma

Journal of neurosurgery, 2018-11, Vol.129 (5), p.1240-1248

2018

Volltextzugriff (PDF)

Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer

International journal of radiation oncology, biology, physics, 2021-07, Vol.110 (3), p.738-741

2021

Volltextzugriff (PDF)

Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer

Nature communications, 2021-05, Vol.12 (1), p.2776-2776, Article 2776

2021

Volltextzugriff (PDF)

Adjuvant therapy in stage III endometrial cancer confined to the pelvis

Gynecologic oncology, 2019-01, Vol.152 (1), p.26-30

2019

Volltextzugriff (PDF)

Peroxisome proliferator-activated receptor γ in bladder cancer: A promising therapeutic target

Cancer biology & therapy, 2009-04, Vol.8 (7), p.575-584

2009

Volltextzugriff (PDF)

Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer

Cancer biology & therapy, 2009-12, Vol.8 (24), p.2339-2347

2009

Volltextzugriff (PDF)

The Role of HMGB1 in Radioresistance of Bladder Cancer

Molecular cancer therapeutics, 2016-03, Vol.15 (3), p.471-479

2016

Volltextzugriff (PDF)

Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy

PloS one, 2018-10, Vol.13 (10), p.e0205746-e0205746

2018

Volltextzugriff (PDF)

Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion

Human pathology, 2013, Vol.44 (1), p.95-102

2013

Volltextzugriff (PDF)

Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype murine bladder cancer model

Cancer biology & therapy, 2024-12, Vol.25 (1), p.2365452

2024

Volltextzugriff (PDF)

Programmed cell death ligand-1 expression in tumor and immune cells is associated with better patient outcome and decreased tumor-infiltrating lymphocytes in uveal melanoma

Modern pathology, 2018-08, Vol.31 (8), p.1201-1210

2018

Volltextzugriff (PDF)

Combining mTOR inhibition with radiation improves antitumor activity in bladder cancer cells in vitro and in vivo: a novel strategy for treatment

PloS one, 2013-06, Vol.8 (6), p.e65257-e65257

2013

Volltextzugriff (PDF)

A novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancer

PloS one, 2013-02, Vol.8 (2), p.e55997

2013

Volltextzugriff (PDF)

Prostate-specific antigen bounce after high-dose-rate prostate brachytherapy and hypofractionated external beam radiotherapy

Brachytherapy, 2014-09, Vol.13 (5), p.450-455

2014

Volltextzugriff (PDF)

Correction: A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer

PloS one, 2013-05, Vol.8 (5)

2013

Volltextzugriff (PDF)

Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy

European urology open science (Online), 2023-11, Vol.57, p.22-29

2023

Volltextzugriff (PDF)

Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer

Bladder cancer, 2017-04, Vol.3 (2), p.105-112

2017

Volltextzugriff (PDF)

Molecular subtyping, tumor infiltration, and trimodal therapy for muscle-invasive bladder cancer: more questions than answers

Translational andrology and urology, 2019-07, Vol.8 (Suppl 3), p.S325-S328

2019

Volltextzugriff (PDF)

PD-1/PD-L1 Immune Checkpoint Inhibition with Radiation in Bladder Cancer: In Situ and Abscopal Effects

Molecular cancer therapeutics, 2020-01, Vol.19 (1), p.211-220

2020

Volltextzugriff (PDF)

Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy

European urology open science (Online), 2022-02, Vol.36, p.26-33

2022

Volltextzugriff (PDF)

Desulfovibrio vulgaris Hildenborough HydE and HydG interact with the HydA subunit of the [FeFe] hydrogenase

Biotechnology letters, 2008-10, Vol.30 (10), p.1765-1769

2008

Volltextzugriff (PDF)

PD42-06 BOOSTING THE COMBINATION OF RADIATION AND ANTI-PD-L1 WITH STING AGONIST IN A PRECLINICAL MUSCLE INVASIVE BLADDER CANCER MURINE MODEL

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

Trehalose inhibits ethanol effects on intact yeast cells and liposomes

Biochimica et biophysica acta, 1994-05, Vol.1191 (2), p.309-316

1994

Volltextzugriff (PDF)

Abstract 3743: Neutrophil extracellular traps and their implication with radioresistance in muscle invasive bladder cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3743-3743

2019

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(73)
Dissertationen
(1)

Sprache

Englisch
(74)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(32)
Humans
(17)
Bladder Cancer
(16)
Oncology
(16)
Animals
(9)
Cancer
(9)
Bladder
(8)
Female
(8)
Urology & Nephrology
(8)
Pathology
(7)
Prognosis
(7)
Tumors
(7)
Urinary Bladder Neoplasms - Pathology
(7)
Aged
(6)
Cell Line, Tumor
(6)
Gene Expression
(6)
Male
(6)
Mice
(6)
Multidisciplinary Sciences
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Integrating novel immunotherapeutic approaches in organ-preserving therapies for bladder cancer

Prognostic factors for progression in atypical meningioma

Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer

Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer

Adjuvant therapy in stage III endometrial cancer confined to the pelvis

Peroxisome proliferator-activated receptor γ in bladder cancer: A promising therapeutic target

Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer

The Role of HMGB1 in Radioresistance of Bladder Cancer

Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy

Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion

Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype murine bladder cancer model

Programmed cell death ligand-1 expression in tumor and immune cells is associated with better patient outcome and decreased tumor-infiltrating lymphocytes in uveal melanoma

Combining mTOR inhibition with radiation improves antitumor activity in bladder cancer cells in vitro and in vivo: a novel strategy for treatment

A novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancer

Prostate-specific antigen bounce after high-dose-rate prostate brachytherapy and hypofractionated external beam radiotherapy

Correction: A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer

Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy

Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer

Molecular subtyping, tumor infiltration, and trimodal therapy for muscle-invasive bladder cancer: more questions than answers

PD-1/PD-L1 Immune Checkpoint Inhibition with Radiation in Bladder Cancer: In Situ and Abscopal Effects

Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy

Desulfovibrio vulgaris Hildenborough HydE and HydG interact with the HydA subunit of the [FeFe] hydrogenase

PD42-06 BOOSTING THE COMBINATION OF RADIATION AND ANTI-PD-L1 WITH STING AGONIST IN A PRECLINICAL MUSCLE INVASIVE BLADDER CANCER MURINE MODEL

Trehalose inhibits ethanol effects on intact yeast cells and liposomes

Abstract 3743: Neutrophil extracellular traps and their implication with radioresistance in muscle invasive bladder cancer

Suchergebnisse filtern